Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04595084 · ClinicalTrials.gov registry record · NA

Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use

A NA study, sponsored by Cambridge Health Alliance.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT04595084 is a NA study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 113 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04595084, a NA study, has completed, sponsored by Cambridge Health Alliance.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

This 3-arm study compares the effectiveness of an (1) 8-week mindfulness-based intervention, MBCT-R (Mindfulness-Based Cognitive Therapy for Resilience During COVID-19)+CHA MindWell vs. (2) iCBT (internet based Cognitive Behavioral Therapy)+ CHA MindWell vs. (3) CHA MindWell remote monitoring and telephone coaching alone on depressive symptoms as measured over the course of 24-weeks by the computerized adaptive mental health (CAT-MH) interview for depression (CAT-DI). Secondary outcomes include rates and levels of alcohol and drug use, as well as the number of required mental health clinician visits (televisits and in-person visits). Exploratory outcomes include stress-related affect reactivity and salivary inflammatory markers (e.g., interleukin-6).

Interventions

  • BEHAVIORAL Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell
  • BEHAVIORAL Internet Cognitive Behavioral Therapy plus CHAMindWell
  • BEHAVIORAL CHAMindWell

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2021-03-15
Est. Completion 2023-03-06
Phase NA

Sponsor

Cambridge Health Alliance

45 total trials

What the Registry Record Tells You About NCT04595084

The ClinicalTrials.gov registry entry for NCT04595084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell is the first listed.

NCT04595084 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04595084 about?

NCT04595084 is a clinical study titled "Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use". This 3-arm study compares the effectiveness of an (1) 8-week mindfulness-based intervention, MBCT-R (Mindfulness-Based Cognitive Therapy for Resilience During COVID-19)+CHA MindWell vs. (2) iCBT (internet based Cognitive Behavioral Therapy)+ CHA MindWell vs. (3) CHA MindWell remote monitoring and te...

What is the current status of trial NCT04595084?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2021-03-15. Estimated completion is 2023-03-06.

What interventions are being tested in trial NCT04595084?

The interventions under investigation include: Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell (BEHAVIORAL), Internet Cognitive Behavioral Therapy plus CHAMindWell (BEHAVIORAL), CHAMindWell (BEHAVIORAL).

Who is sponsoring clinical trial NCT04595084?

This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.